Table 3.
Clinical outcomes between the placebo arm vs. all FMT arms combined at week 10
| Clinical Outcomes | FMT arms (N = 24) |
Placebo (n = 11) |
P-value |
|---|---|---|---|
| Change in IBS-SSS | −75.6 (122.8) | −93.4 (97.1) | 0.68 |
| Change in IBS-QoL | 14.5 (19.4) | 9.4 (18.4) | 0.47 |
| Number with adequate relief |
10 (41.7%) | 4 (36.4%) | 0.10 |
| Number with global improvement |
7 (29.2%) | 2 (18.2%) | 0.69 |
| IBS-SSS Responders | 12 (52.2%) | 7 (63.6%) | 0.72 |
| IBS-QoL Responders | 9 (37.5%) | 4 (36.4%) | 0.99 |
Note: Change in score is the difference between week 10 and baseline. A negative value for change in IBS-SSS indicates an improvement in symptoms. A positive value for change in IBS-QoL indicates an improvement in quality of life.